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ABSTRACT: Measurement of nitric oxide in exhaled air is a noninvasive method to
assess airway inflammation in asthma. This study was undertaken to establish the
reference range of exhaled NO in healthy school-aged children and to determine the
influence of ambient NO, noseclip and breath-holding on exhaled NO, using an off-line
balloon sampling method.
All children attending a primary school (age range 8–13 yrs) underwent NO
measurements on two occasions with high and low ambient NO. Each time, the children
performed four expiratory manoeuvres into NO-impermeable balloons, with and
without 10 s of breath-holding and with and without wearing a noseclip. Exhalation
flow and pressure were not controlled. NO was measured within 4 h after collection, by
means of chemiluminescence. All children completed a questionnaire on respiratory and
allergic disorders, and performed flow/volume spirometry.
With low ambient NO, the mean exhaled NO value of 72 healthy children with
negative questionnaires and normal lung function was 5.1¡0.2 parts per billion (ppb)
versus a mean of 6.8¡0.3 ppb in the remaining 49 children with positive questionnaires
for asthma and allergy, and/or recent symptoms of cold (p~0.001). Exhaled and
ambient NO were significantly related, especially with ambient NOw10 ppb (r~0.86,
p~0.0001 versus r~0.34, p~0.004 for ambient values v10 ppb). The use of a
noseclip, with low ambient NO and without breath-holding, caused a small decrease in
exhaled NO values (p~0.001). The effect of breath-holding on exhaled NO depended
on ambient NO. With ambient NO w10 ppb, exhaled NO decreased, whereas with
ambient NO v10 ppb, exhaled NO increased after 10 s breath-hold.
It is concluded that off-line sampling in balloons is a simple and, hence, attractive
method for exhaled nitric oxide measurements in children which differentiates between
groups with and without self-reported asthma, allergy and colds, when ambient nitric
oxide is v10 parts per billion. Wearing a noseclip and breath-holding affected
measured values and should, therefore be standardized or, preferably, avoided.
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Nitric oxide (NO) is a reactive free radical gas
produced by various cells within the respiratory tract.
It plays an important role in the pathophysiology of
inflammatory airway disease and can be detected in
exhaled air [1–4]. There is now convincing evidence
that NO in exhaled air (eNO) is a noninvasive marker
of airway inflammation in various airway disorders
[1, 5, 6]. Recently, slow exhalation from total lung
capacity with a constant flow against a resistance was
recommended for measurement of eNO [6]. However,
this manoeuvre is difficult to perform for many
children [7], and requires the presence of an NO-
analyser and equipment to measure flow with a visual
feedback control. The present authors have developed
a simple off-line, single breath, balloon sampling
method to measure eNO. Blowing air in a balloon is
feasible even for young children, and produces values
similar to those of end-expiratory plateaus [7, 8]. Off-
line sampling has the advantage that children may be
studied at home or school, and that it can be used for
large epidemiological studies, independent from the
direct presence of an NO-analyser. The aim of this
study was to establish a reference range of eNO
sampled in balloons, of a large group of healthy
school-aged children. Furthermore, the influence of
ambient NO, the effect of 10 s of breath-holding and
the use of a noseclip was examined.
Patients and methods
All pupils of a primary school (n~129) partici-
pated. They were interviewed with validated ques-
tionnaires on asthma, allergy, eczema and rhinitis,
translated from the core questionnaires on wheezing,
rhinitis amd eczema of the International Study of
Asthma and Allergies in Childhood (ISAAC) [9]. In
addition they were asked about recent symptoms of
cold (stuffy or running nose, sneezing, coughing, sore
throat, with or without fever). Measurement of eNO
was performed on two occasions in the same children.
On the first occasion, the ambient NO was high
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(median 35 parts per billion (ppb), range 15–188 ppb).
At that time, 91 children (mean age 10 yrs) had
negative questionnaires on asthma, allergy and
eczema (all questions answered negatively) and did
not report symptoms of cold within the 3 weeks before
the measurements. On the second occasion 3.5 months
later, ambient NO was low (median 7.0 ppb, range
1.5–9.0 ppb). At that time, 8 children were absent, 72
of the 91 who initially had negative ISAAC ques-
tionnaires reported no symptoms of cold, and 49 had
either positive ISAAC questionnaires or reported a
recent cold. Measurements took place during several
sessions at each occasion, always between 14.00 and
16.00 h. Ambient NO was drawn and stored for later
analysis before and after each session, and the mean of
these two samples was taken as the ambient NO
concentration at that session. All children were self-
reported never-smokers, never had had any other
chronic illness, and used no medication. The study
was approved by the hospital ethical committee.
Exhaled air sampling and nitric oxide measurements
The children were asked to take a deep oral breath
and exhale via a piece of plastic tubing into a mylar
balloon with a maximum content of 1,750 mL. These
balloons were impermeable to and nonreactive with
NO [10]. The plastic tube (internal diameter 3.7 mm
and length 5 cm) worked as a fixed flow restrictor,
causing a positive mouth pressure during the exhala-
tion manoeuvre. Preliminary experiments showed that
with a flow of 250 mL?min-1, this pressure is
6 cmH2O. At the school, exhalation flow and mouth
pressure were not monitored. Subjects filled the
balloon within 3–5 s. The range of expiratory volumes
which were collected was 250–1,750 mL, the extra-
polated expiratory flows thus ranged between
250–600 mL?s-1.
All subjects performed expiratory manoeuvres into
four balloons: 1) immediate exhalation with a
noseclip; 2) immediate exhalation without a noseclip;
3) exhalation after breath-holding for 10 s with a
noseclip; 4) exhalation after breath-holding for 10 s
without a noseclip. All measurements were performed
with the children seated. The NO concentration in
balloons was measured within 4 h after collection. Air
was drawn out of the balloons at 200 mL?min-1 by a
chemiluminescence analyser (Sievers 280, Boulder,
CO, USA) with a response time of 200 ms. The NO
profile showed a rapid rise to a steady NO plateau, at
which eNO was calculated. The analyser was regulary
calibrated according to the manufacturer9s guidelines,
with two different certified NO gases (100 ppb and 9
parts per million (ppm)) and a certified NO free air
mixture (HoekLoos, Barendrecht, the Netherlands).
Lung function
All subjects performed maximal expiratory flow/
volume spirometry immediatly after eNO was
collected in the balloons on the first occasion. Flow/
volume curves were obtained in triplicate using a
calibrated single breath electronic screening spirometer
(Vicatest P2A, Mijnhardt, Zeist, the Netherlands).
Results of expiratory forced vital capacity (FVC) and
forced expiratory volume in one second (FEV1) were
expressed as percentage of predicted values [11].
Stability of exhaled nitric oxide in balloons
Five subjects each filled one balloon with orally
exhaled air and one with nasally exhaled air. These
balloons were sealed and stored at room temperature.
During a period of 6 h, air was sampled for NO
measurements at hourly intervals.
Data analysis
Data of NO measurements were fed into a
computer at a sampling rate of 20 Hz. Mean values
during 30 s sampling of the plateau were calculated.
Correlation between eNO and other variables were
analysed in a multiple regression model. In this model,
eNO was entered as the dependent variable and
ambient NO, sex, age and FEV1 were entered as
independent variables. Differences between healthy
and "diseased" groups were evaluated with a t-test for
independent samples. Differences between eNO values
at high and low ambient NO within groups were
tested using a paired sample t-test. The relationship
between eNO and ambient NO concentrations was
tested with Spearman9s rank test. Data are reported as
mean¡SEM. In all statistical comparisons, a two-tailed
p-value v0.05 was considered significant.
Results
Characteristics of the study population are given in
table 1. There were no differences in age, male/female
ratio, anthropometric data and lung function between
healthy and "diseased" groups at both sampling
moments.
Reference values
All children performed the sampling procedures
without difficulty. Values obtained in 72 healthy
children, not wearing noseclips, without breath-hold,
and while ambient NO was below 10 ppb, are
considered as reference values and show a normal,
symmetrical distribution with a mean level of
5.1¡0.2 ppb (95% reference interval 1.7–8.5 ppb).
Exhaled NO was similar in male and female children
(means 5.1 ppb and 4.9 ppb, respectively, p~0.15).
There was no significant correlation between eNO and
FVC or FEV1 (p~0.56). A significant positive
correlation was found between age and eNO; for
every 10 months of increasing age eNO increased
0.3¡0.1 ppb (p~0.013). Individual data and 95%
reference interval are given in figure 1. The children of
the "diseased" group (n~49) with positive question-
naires on asthma, rhinitis, and/or eczema, and/or
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symptoms of cold within 3 weeks before eNO
measurements, with ambient NO v10 ppb, showed
a significantly higher mean eNO than the correspond-
ing healthy group (6.8¡0.3 ppb, p~0.001). The mean
eNO values of the healthy and "diseased" groups of
children under the different measurement conditions,
with ambient NO v10 ppb, are given in table 2.
Effect of ambient nitric oxide
High concentrations of ambient NO led to sig-
nificantly higher eNO values in healthy children:
19.2¡1.6 ppb with ambient NO w10 ppb versus
5.1¡0.2 ppb with ambient NO v10 ppb (pv0.0001).
Exhaled NO values and ambient NO concentrations
were significantly related (fig. 2). With ambient NO
levels w10 ppb this relationship was stronger than
with levels v10 ppb (r~0.86, pv0.0001 versus
r~0.34, p~0.004, respectively). Between 0 and
10 ppb, eNO increases with 0.2¡0.2 ppb?ppb increase
of ambient NO-1. Wearing a noseclip had no influence
on the observed relation between eNO and ambient
NO.
Effect of noseclip
The noseclip significantly reduced eNO values when
ambient NO wasv10 ppb. In 72 healthy children, the
mean eNO value was 4.5¡0.2 ppb with, and
5.1¡0.2 ppb without noseclip (p~0.001). There was
no significant effect of a noseclip on eNO values under
all other measurement conditions: high ambient NO
levels with (p~0.2) or without breath-holding
(p~0.9) and low ambient NO levels with breath-
holding (p~0.4).
Effect of breath-holding
In healthy children, 10 s of breath-holding resulted in
an increase in eNO from 5.1¡0.2 ppb–6.4¡0.4 ppb
(pv0.0001) with ambient NO v10 ppb. In contrast,
10 s of breath-holding produced a significant reduction
of eNO from 19.2¡1.6 ppb–9.6¡0.8 ppb (pv0.0001)
with ambient NOw10 ppb.
Table 1. – Patient characteristics on two occasions, with high and low ambient nitric oxide (NO)
Characteristic Ambient NO v10 ppb. Ambient NO w10 ppb.
Healthy Diseased** Healthy Diseased
Subjects n 72 49 91 38
Sex M/F 31/41 28/21 46/45 19/19
Age months 123.8¡1.8 123.3¡2.2 125¡1.6 120.2¡2.5
Height cm 144.3¡1.2 144.4¡1.6 144.6¡1.1 142.8¡2.5
Weight kg 37.8¡1.0 38.8¡1.2 38.0¡0.9 38.0¡1.5
FVC % pred 98¡1 99¡1 98¡1 100¡2
FEV1 % pred 99¡1 99¡1 99¡1 99¡2
Data are presented as mean¡SD. ppb: parts per billion; M: male; F: female; FVC: forced vital capacity; FEV1: forced



































































Fig. 1. – Exhaled nitric oxide (NO) of 72 healthy school children
versus age. Values are from children without reported asthma,
allergy or recent cold, and were measured when ambient NO was
v10 parts per billion (ppb). All measurements were done without
breath hold or noseclip. There is a small but significant increase in
NO with increasing age, corresponding to 0.3¡0.1 ppb per 10
months (r~0.3, p~0.013). Lines indicate the 95% reference interval.
Table 2. – Nitric oxide (NO) values of schoolchildren with and without reported symptoms of asthma, allergy or colds
(indicated as healthy and diseased, respectively), with and without noseclip or breath-holding, measured when ambient
NO was v10 ppb
Status Subjects NC - NC z NC z NC -
n BH - BH - BH z BH z
Healthy 72 5.1¡0.2 (2.1–10.9) 4.5¡0.2** (1.1–9.5) 6.2¡0.4** (2.2–20.5) 6.4¡0.4*** (2.7–21.6)
Diseased 49 6.8¡0.3* (2.4–15.3) 5.9¡0.4* (1.8–14.3) 8.9¡1.1* (2.0–46.2) 8.3¡0.9* (2.3–32.1)
Data are presented as mean¡SD (range). NC: nose clip; BH: breath-holding; z: worn/performed; -: not worn/performed.
*: pv0.001 compared to healthy children, same measurement conditions; **: pv0.001 compared to healthy children without
noseclip and breath-hold; ***: pv0.0001 compared to healthy children without noseclip and breath-hold.
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Stability of exhaled nitric oxide in balloons
The NO concentration in 5 mylar-balloons with
nasal air was 36.4¡1.8 ppb and with oral air
7.5¡0.9 ppb. Nasal and oral NO concentrations in
the balloons were stable for at least 6 h (fig. 3).
Discussion
In this study, a reference range of eNO obtained
off-line with balloon sampling in a large group of
healthy school-aged children was defined. The mean
eNO concentration of healthy children in the study is
in agreement with eNO concentrations of healthy
children from a number of previous studies [12–16].
Furthermore, it has been shown that a number of
methodological factors influence eNO collected off-
line in balloons, including ambient NO, the use of a
noseclip and breath-holding. Significant differences
between children with and without self-reported
asthma, allergy and colds were deteted, suggesting
that this method is sufficiently sensitive to detect
minor degrees of airway inflammation in groups of
otherwise healthy school-aged children.
There are a number of factors that should be
considered when comparing the present simple off-line
sampling technique with more complicated on-line
sampling techniques where flow is controlled and the
NO signal displayed during exhalation.
It has previously been shown that despite lack of
flow standardization, off-line sampling in balloons
produces eNO values that are reproducible and
similar to those of end-expiratory plateaus measured
on-line with constant flow [7]. It has also been shown
that eNO is flow-dependent, but mainly at flows of
#150 mL?s-1 [17–19], whereas eNO is much less flow-
dependent at higher flows. The children in the present
study blew relatively high flows of¢250 mL?s-1. This
could explain why eNO in balloons is reproducible
despite a lack of flow standardization [7].
In a previous study, an excellent within-subject
short-term repeatability of eNO was shown, with an
intraclass correlation coefficient (ri) of 0.91, using the
same technique without wearing a noseclip [7]. Small
alterations of this original sampling technique, like the
use of a noseclip or 10 s breath-holding, could
potentially influence the repeatability. It has previously
been shown that short-term repeatibility in clinicallly
stable allergic asthmatic children was also excellent
when a noseclip was used (ri~0.96) [7, 8, 14, 21]. This
study did not specifically investigate the influence of
10 s breath-holding on the repeatability of eNO
obtained with the off-line balloon method, and no
such data are available in the literature.
Contamination with nasal NO is another potential
problem with off-line sampling. An expiratory resist-
ance is recommended to isolate the lower airway gas
from gas with much higher NO concentrations
produced in the nose and paranasal sinuses [6]. In
the present study, balloons were filled via a plastic
tube during a single oral exhalation. The tube worked
as a fixed flow restrictor which causes a positive
mouth pressure during the exhalation manoeuvre. It
has been shown in adults that a mouth pressure of
4 cmH2O is sufficient to keep the soft palate closed,
thus preventing contamination with NO from upper
airways [22]. Studies on mouth pressure and velum
closure were performed in adults; it may well be that
lower pressures close the velum in children. The lowest
estimated mean exhalation flow of 250 mL?s-1 in this
study produced a mouth pressure of 6 cmH2O. This
should be sufficient to close the velum, and the
authors are therefore confident that contamination
with NO from the upper airways, despite the simple
set-up without monitoring of flow or pressure during
exhalation, did not occur to an important degree.
The potential effect of NO in the dead space air
volume on eNO in the balloon is another point of
concern. Children have a smaller dead space volume
than adults which, in a similar balloon volume, will
cause a smaller effect on NO values. The authors
speculate that, in children, the effect of the dead space
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Fig. 2. – Exhaled nitric oxide (NO) versus ambient NO on days
with ambient values w10 parts per billion (ppb) in 91 healthy
children. Note that both axes are logarithmical. There is a signifi-
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Fig. 3. – Nitric oxide concentrations (NO) in mylar-balloons,
stored for 6 h at room temperature. $: mean (NO) from 5 bal-
loons containing nasal air; #: mean (NO) from 5 balloons con-
taining orally exhaled air. Concentrations were stable in time.
ppb: parts per billion.
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NO is v10 ppb, and when subjects inhale orally
before exhaling into the balloon, as was done in the
present study.
Previous studies on the effect of ambient NO on
eNO vary remarkably. Some authors found no
influence of ambient NO on eNO values [23–27],
others found important effects [28–32]. This study
found a strong positive relationship between ambient
NO concentrations and eNO in balloons. The varia-
tion of sampling techniques used in the different
studies probably explains the differences. As an
example, CORRADI et al. [32] found no relationship
between ambient NO and eNO in balloons, with
ambient NO v35 ppb, but the expiration in their
study in adults took ¢20 s compared to 3–5 s in the
present study. This may explain the difference, as this
study found that breath-hold significantly reduced the
effect of high ambient NO on exhaled values. The
positive relationship between ambient and eNO was
more pronounced with high ambient levels, but there
was also a positive correlation at ambient NO levels
below 10 ppb. The magnitude of this effect, a mean
rise of eNO 0.2 ppb for each 1 ppb rise in ambient
NO, is small compared to the differences in eNO
between healthy and "diseased" children. To minimize
the effect of ambient NO on eNO, the present authors
recommend that eNO should not be measured when
ambient NO is above 10 ppb. Ambient NO should be
recorded, or sampled in balloons and analysed later.
Alternatively, NO-free air may be inhaled before
sampling, but this makes the method more compli-
cated and formal comparisons of these approaches
have not been performed.
The present study found a significant correlation
between an increase in eNO concentrations and
increasing age in healthy children. A possible explana-
tion is the influence of the different dead space air
volumes on eNO values in balloons. It could also be
speculated that this correlation is caused by increasing
nasal contamination of the eNO with age, due to
development and pneumatization of the paranasal
sinuses in childhood. Indeed, nasal NO increases with
age, reaching levels similar to those in adults at the age
of y10 yrs, and this corresponds roughly with the
period of sinus development [33]. However, oral
pressures were probably sufficient to close the velum
and prevent contamination by nasal NO [22].
Furthermore, FRANKLIN et al. [34] recently described
a positive correlation between eNO and age in a
comparable group of healthy children using an on-
line, single breath, plateau technique at a mouth
pressure of 15 cmH2O [34]. Other eNO studies in
children have not been able to demonstrate a relation-
ship of eNO with age [14, 15, 30]. However, a number
of methodological differences of the different studies
makes it difficult to compare results, for instance,
differences in age, in sampling methods with eNO
values obtained in different ways, and in dealing with
the ambient NO.
It has been stated that using a noseclip enhances
nasal contamination of eNO, although there are no
data to support this [2, 10, 17]. Several investigators
routinely require subjects to wear noseclips during NO
measurements [10, 26, 31, 35], while others do not
[17, 21, 36]. Without a noseclip, diffusion of NO
through the nares as well as into the posterior
nasopharynx is possible; with a noseclip only diffusion
towards the pharynx can occur, and this would
increase contamination with high nasal NO levels.
Using the present off-line, single breath, balloon
sampling method with an expiratory resistance, it
was found that a noseclip in combination with low
ambient NO levels causes a small but significant
decrease in exhaled NO values. A possible explanation
is that a noseclip prevents a minimal nasal inspiration,
thus preventing contamination of eNO with nasal NO.
Although a noseclip only minimally affected eNO, the
present data do not argue against the European
Respiratory Society Task Force recommendation not
to use noseclip during NO measurement [6].
Prior studies have shown that breath-holding
increases eNO in asthmatics and in healthy subjects in
a time dependent fashion [10, 17, 37, 38]. However,
others have shown that when 40 ppm is inhaled, a
breath-hold of several seconds reduced NO in exhaled air
to 1–3 ppm [25]. This decrease may be caused by rapid
uptake of NO by haemoglobin in the lung capillaries
[17, 25, 39]. This present study found that the effect of
breath-holding on eNO depends on ambient NO; with
high levels, breath-holding reduces NO, whereas with
low levels it increases eNO. It is not likely that these
results are influenced by nasal contamination during
breath-holding or in the oral expiration phase, as shown
earlier with an inert tracer gas [22].
It is concluded that off-line measurement of nitric
oxide sampled in balloons, is a simple and feasible
method of measuring exhaled nitric oxide in children.
Off-line sampling has the important advantage that it
offers independence from the presence of a nitric oxide
analyser. Off-line balloon sampling without use of a
noseclip and without breath-hold, and with ambient
nitric oxide levels v10 parts per billion, shows
differences between healthy children and those with
self-reported asthma, allergy or cold, confirming that
exhaled nitric oxide may be used as a surrogate
marker of airway inflammation. The simplicity of this
method makes it attractive for studies in larger
populations, where differences between groups can
be detected.
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